Navigation Links
C.R. Bard Vaginal Mesh Lawsuits Move Forward, With Issuance of New Pretrial Order in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports

New York, New York (PRWEB) August 04, 2014

Vaginal mesh lawsuits ( filed against C.R. Bard, Inc. continue to move forward in courts around the country, Bernstein Liebhard LLP reports. According to an Order dated July 30th, the federal judge overseeing thousands of such cases in the U.S. District Court, Southern District of West Virginia, has established new discovery procedures aimed at further streamlining the litigation process. At the conclusion of the pre-trial proceedings outlined in the Order, the Court will transfer each directly-filed case to a federal district of proper venue, while the vaginal mesh lawsuits transferred by the to the Southern District of West Virginia U.S. Judicial Panel on Multidistrict Litigation will be remanded to the federal district where they were originally filed. (In re C.R. Bard Inc. Pelvic Repair System Products Liability Litigation, MDL No. 2187)

“Our Firm is representing hundreds of women who allegedly suffered serious transvaginal mesh complications due to devices marketed by C.R. Bard and other companies. We are pleased to see these cases moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. Firm partner, Jeffrey S. Grand, is a member of the Plaintiffs' Steering Committee in the federal C.R. Bard litigation. Bernstein Liebhard LLP continues to offer free legal evaluations to women who allegedly suffered serious injuries following implantation of devices manufactured by C.R. Bard, Inc., as well as American Medical Systems, Inc., Ethicon, Inc. and Boston Scientific Corp.

Vaginal Mesh Lawsuits
Court documents indicate that C.R. Bard is named a defendant in more than 9,000 vaginal mesh lawsuits that are pending in the Southern District of West Virginia. All of the lawsuits claim that surgical mesh devices marketed by the company to treat pelvic organ prolapse and stress urinary incontinence caused recipients to suffer serious transvaginal mesh complications, including chronic pain, mesh erosion, scarring and organ damage. The claims further allege that C.R. Bard failed to subject its transvaginal mesh devices to appropriate testing in order to ensure their safety and effectiveness.

In addition to his work on the federal multidistrict litigation involving C.R. Bard, Bernstein Liebhard partner, Jeffrey S. Grand, is also serving on the Plaintiffs' Steering Committees in a number of other consolidated proceedings underway in the Southern District of West Virginia, including: In re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation - MDL No. 2325; In re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation - MDL No. 2326; and In re: Ethicon, Inc. Pelvic Repair Systems Products Liability Litigation - MDL No. 2327.

Mr. Grand was also appointed Co-Liaison Counsel in two multicounty litigations that were established in New Jersey's Atlantic County Superior Court for vaginal mesh lawsuits filed against C.R. Bard and Ethicon. He was also a member of the trial team for the proceedings' first Ethicon mesh trial. That case ended in March 2013, after a woman injured by a Gynecare Prolift device was awarded more than $11 million in damages. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)

Alleged victims of serious transvaginal mesh complications may be entitled to compensation for medical bills, lost wages, pain and suffering, and other injury-related damages. To learn more about the ongoing transvaginal mesh litigation, please visit Bernstein Liebhard LLP's website or the Firm's Facebook page: To obtain a free, confidential and no-obligation case review, please call 800-511-5092.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact Information:

Felecia L. Stern, Esq.
Bernstein Liebhard LLP

Read the full story at

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Transvaginal Mesh Lawsuit News: Mesh Maker Bard Settles 500 Lawsuits, the Rottenstein Law Group LLP Reports
2. Ethicon Transvaginal Mesh Lawsuits Mount in New Jersey Litigation, as New Case List Reports More Than 6,800 Filings
3. Texas Transvaginal Mesh Recipients Press State’s Attorney General Office to Take Action Against Manufacturers, Baron and Budd Reports
4. San Diego Product Liability Firm Provides Commentary on the Latest Developments in Transvaginal Mesh Litigation
5. Ethicon Transvaginal Mesh Lawsuits Move Forward, With Scheduling of Hearing in Federal Litigation, Bernstein Liebhard LLP Reports
6. Transvaginal Mesh Lawsuit News: FDA Rejects Petition Seeking Ban and Global Recall of All Transvaginal Mesh Products, Bernstein Liebhard LLP Reports
7. Court Overseeing First Ethicon Transvaginal Mesh Lawsuit Trial in New Jersey Upholds $11 Million+ Jury Award, Bernstein Liebhard LLP Reports
8. Federal Judge Overseeing Ethicon Vaginal Mesh Lawsuit Denies Summary Judgment on Certain Claims, Bernstein Liebhard LLP Reports
9. Transvaginal Mesh Lawsuit News: Federal Plaintiff Allowed to Pursue Claims Related to Use of Prolene in Ethicon Mesh Products, Bernstein Liebhard LLP Reports
10. Nearly 60,000 Vaginal Mesh Lawsuit Claims Filed Against Seven Different Pelvic Mesh Manufacturers
11. Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... Florida Hospital Tampa is the first health ... in the state of Florida. , vBloc® Therapy is a vagal blocking therapy, delivered via ... with a body mass index (BMI) of at least 40 to 45 kg, or a ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... continuing medical education (CME), today announced that the first annual School of Gastrointestinal ... , “The prevention, detection and treatment of gastrointestinal cancers are undergoing transformational change, ...
(Date:12/1/2015)... ... , ... Califia Farms , one of the fastest growing natural beverage ... honors in Beverage World Magazine’s Global Packaging Design Awards, taking home the Gold in ... as a 2015 U.S.A. Taste Champion in the American Masters of Taste Championships for ...
(Date:12/1/2015)... Middletown, PA (PRWEB) , ... December 01, 2015 ... ... separate environments; however, there are professionals who believe that with innovative technologies and ... services allows the patient to get the benefit of a dual-approach to his ...
(Date:12/1/2015)... ... December 01, 2015 , ... December 1, 2015 -- ... the company’s growing product line of food safety and seafood fraud prevention tools. ... nerka) – allow InstantLabs to offer fast, reliable species identification for the four ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... VANCOUVER , Dec. 1, 2015  Following an ... (NASDAQ: OGXI ) announced today that its Phase ... interim futility analysis of the intent-to-treat (ITT) population. In ... identified by the DMC. Both the DMC and OncoGenex ... expected in the second half of 2016, depending on ...
(Date:12/1/2015)... , Dec. 1, 2015  CytoSorbents Corporation (NASDAQ: ... commercializing its CytoSorb® blood purification technology to reduce ... world, today announced that Dr. Phillip Chan ... to participate in the LD Micro Main Event ... Conference, both of which will be held in ...
(Date:12/1/2015)... Colo. , Dec. 1, 2015 /PRNewswire/ ... ) today announced that its Chief Executive ... at the Oppenheimer Annual Healthcare Conference in ... participate in the conference through a webcast ... , --> ...
Breaking Medicine Technology: